EC Number   |
Activating Compound |
Reference |
|---|
   2.7.11.23 | cyclin H |
required by Cdk7 |
662740 |
| 2.7.11.23 | cyclin T1 |
is in a complex with cdk9 and forms P-TEFb |
681696 |
| 2.7.11.23 | cyclin T1 |
required by Cdk9 |
662740 |
| 2.7.11.23 | CYCLINT protein |
endogenous from Medicago sativa and from Medicago trunculata, the enzyme is organized in the CDKC-1/CYCLINT-1 kinase complex, CYCLINT protein is a specific interactor of the enzyme forming the active kinase complex which localizes to the nucleus |
663093 |
| 2.7.11.23 | DNA |
activation |
640980 |
| 2.7.11.23 | Mediator |
stimulates the CTD kinase activity of TFIIH manyfold, immobilized holo-RNAPII can be separated into RNAPII and Mediator |
680768 |
| 2.7.11.23 | more |
binding of Spt6 to the P-TEFb/Ser2P CTD stimulates the kinetics of mRNA export. Because P-TEFb counteracts NELF- and DSIF-induced pausing in cell-free transcription reactions, at least part of its activity does not depend upon chromatin |
686270 |
| 2.7.11.23 | more |
DNA-PK is active only in the presence of DNA, no activity in absence of DNA |
740824 |
| 2.7.11.23 | more |
Epstein-Barr virus EBNA 2, stimulates both RNA polymerase II recruitment and RNA polymerase II phosphorylation by CDK9 on serine 5 of the C-terminal domain in vivo |
682208 |
| 2.7.11.23 | more |
infection with human cytomegalovirus increases Cdk7 and Cdk9 activities and phosphorylation levels of the large subunit of RNA polymerase II CTD |
662740 |
